Alcobra Ltd (ADHD)

4.96
NASDAQ : Health Care
Prev Close 4.96
Day Low/High 0.00 / 0.00
52 Wk Low/High 3.15 / 9.14
Avg Volume 75.60K
Exchange NASDAQ
Shares Outstanding 27.56M
Market Cap 139.46M
EPS -0.90
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

7 Stocks Under $10 Making Big Moves Higher

7 Stocks Under $10 Making Big Moves Higher

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

RSI Alert: Alcobra (ADHD) Now Oversold

RSI Alert: Alcobra (ADHD) Now Oversold

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Alcobra Enters Oversold Territory (ADHD)

Alcobra Enters Oversold Territory (ADHD)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Breadth Is Key Over the Next Few Days

NYSE breadth made a minor higher high, whereas the S&P did not.

Alcobra Placebo Beats Drug in Failed Genetic Disease Study

Alcobra Placebo Beats Drug in Failed Genetic Disease Study

Alcobra's MDX has now failed to demonstrate benefit for patients in two different clinical trials.

Alcobra Ltd. To Present Results Of Phase II Fragile X Trial In A Conference Call & Webcast Presentation On Wednesday, June 24

Alcobra Ltd. To Present Results Of Phase II Fragile X Trial In A Conference Call & Webcast Presentation On Wednesday, June 24

Conference Call and Webcast Scheduled for 8:00 a.m. Eastern Time Tomorrow